Histologic and immunophenotypic features prior to transformation in patients with transformed cutaneous T-cell lymphoma: Is CD25 expression in skin biopsy samples predictive of large cell transformation in cutaneous T- cell lymphoma?

American Journal of Dermatopathology

Volumn 20, Issue 1, 1998, Pages 1-6

  Stefanato, Catherine M ^a,b   Tallini, Giovanni ^a   Crotty, Paul L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD25; Cutaneous T Cell Lymphoma; Immunohistopathology; Large Cell Transformation

Indexed keywords

CD4 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; LYMPHOID CELL; MALE; MALIGNANT TRANSFORMATION; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SEZARY SYNDROME; SKIN BIOPSY; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CD4-CD8 RATIO; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0031937840     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199802000-00001     Document Type: Article

References (38)

1. Alibert JL. Description des maladies de la peau: observees a l'Hopital Saint Louis, et exposition des meilleures methodes suivies pour leur traitment. Paris: Chez Barrois, l'aine et Fils 1806:167.
2. Edelson RL (NIH Conference). Cutaneous T-cell lymphomas. Perspective. Ann Intern Med 1975;83:548-52.
3. Wood GS. Benign and malignant cutaneous lymphoproliferative disorders including mycosis fungoides. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore: Williams and Wilkins, 1992:917-52.
4. Wood GS, Matthews MJ. Diagnosis of T-cell malignant lymphoproliferative disorders of the skin. In: Jaffe ES, ed. Surgical pathology of the lymph nodes and relative organs. Philadelphia: WB Saunders Company, 1995:413-47.
5. Kerl H, Cerroni L, Burg G. The morphologic spectrum of T cell lymphomas of the skin: a proposal for a new classification. Semin Diagn Pathol 1991;8:55-61.
6. MacKie RM. Dermatological aspects of leukemias and lymphomas. In: Rook A, Wilkinson DS, Ebling JFG, Champion RH, Burton JL, eds. Textbook of Dermatology. Oxford: Blackwell Scientific Publications, 1986:1727-53.
7. Epstein EH, Levin DL, Croft JD. Mycosis fungoides: survival, prognostic features, response to therapy and autopsy findings. Medicine 1972;15:61-72.
8. Braverman IM. Transformation in cutaneous T-cell lymphoma. J Invest Dermatol 1993;10:249-50.
9. Cerroni L, Rieger E, Hodl S. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large cell lymphoma. Am J Surg Pathol 1992;16:543-52.
10. Kaudewitz P, Burg G, Stein H. Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. In: Vloten WA van, Willenze R, Lange Vejlsgaard G, Thomsen K, eds. Cutaneous Lymphoma. Curr Probl Dermatol. Basel, Karger, 1990;19:150-6.
11. Lever WF, Schamberg-Lever G. Histopathology of the skin. Philadelphia: JB Lippincott Company, 1990:806-46.
12. Salhany KE, Cousar JB, Greer JP, et al. Transformation of cutaneous T-cell lymphoma to large cell lymphoma: a clinicopathologic and immunologic study. Am J Pathol 1988;132:265- 77.
13. Chan WC, Dekmezian R. Phenotypic changes in large cell transformation of small cell lymphoid malignancies. Cancer 1986;57: 1971-8.
14. Wolfe JT, Chooback L, Finn DT, et al. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor. J Clin Oncol 1995;13:1751-7.
15. Greer JP, Salhany KE, Cousar JB. Clinical features associated with transformation of cerebriform T cell lymphoma to a large cell process. Hematol Oncol 1990;8:215-27.
16. Vonderheid EC, Tam DW, Johnson WC et al. Prognostic significance of cytomorphology in the cutaneous T cell lymphomas. Cancer 1981;47:119-25.
17. Sussman J, Duray P, Braverman I et al. Extracutaneous malignant lymphoma with transformed cells in mycosis fungoides [Abstract], Lab Invest 1985;52:66.
18. Dmitrovsky E, Matthews MJ, Bunn PA et al. Cytologic transformation in cutaneous T-cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol 1987;5:208-15.
19. Rappaport H, Thomas LB. Mycosis fungoides: the pathology of extracutaneous involvement. Cancer 1974;34:1198-229.
20. Wood GS, Hoppe RT, Warnke RA, et al. Evidence that mycosis fungoides (MF) and transformed MF arise from the same T-cell clone [Abstract]. J Cutan Pathol 1991;18:397.
21. Bunn PA, Lamberg SI. Report of the committee on staging and classification of cutaneous T-cell lymphoma. Cancer Treat Rep 1979;63:725-8.
22. Patterson J, Edelson R. Cutaneous T-cell lymphoma and other leukemic and lymphomatous infiltrates of the skin. In: Fitzpatrik TB, Eisen AZ, Wolff K, et al., eds. Dermatology in General Medicine. New York: McGraw-Hill, 1987:1087-118.
23. Tallini G, Parham DM, Diaz P, et al. Myogenic regulatory protein expression in adult soft tissue sarcomas, a sensitive and specific marker of skeletal muscle differentiation. Am J Pathol 1994;144: 693-701.
24. Weiss LM, Crabtree GS, Rouse RV. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol 1985;118:316-24.
25. Van der Putte SCJ, Toonstra J, Van Wichen DF. Aberrant immunophenotypes in mycosis fungoides. Arch Dermatol 1988;124: 373-80.
26. Munashi O, Masayoshi J, Tomomichi O, et al. Differences in IL-2 receptor levels between mycosis fungoides and cutaneous type adult T-cell leukemia/lymphoma in the early stages of the disease. J Invest Dermatol 1994;102:710-5.
27. Kaudewitz P, Josimovic-Alasevic O, Diamantstein T, et al. Soluble IL-2 receptor serum levels in cutaneous T-cell lymphoma: correlation with clinical stage and IL-2R receptor status in cutaneous infiltrates [Abstract]. J Invest Dermatol 1988;91:386-7.
28. Wasik MA, Vonderheid EC, Bigler RD, et al. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Arch Dermatol 1996;132:42-7.
29. Leonard WJ, Depper JM, Uchiyama T, et al. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature 1982;300:267-9.
30. Uchiyama T, Broder S, Waldmann TA. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells: I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol 1981;126:1393-7.
31. Uchiyama T, Nelson DL, Fleisher TA, et al. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T-cells: II. Expression of Tac antigen on activated cytotoxic killer T-cells, suppressor cells, and on one of two types of helper T-cells. J Immunol 1981;126:1398-403.
32. Szeimies RM, Rueff F, Kaudewitz P. Soluble interleukin-2 re- ceptor serum levels in mycosis fungoides. Cancer 1992;70:2338- 41.
33. Bernengo MG, Fierro MT, Novelli M, et al. Soluble interleukin-2 receptor in Sezary syndrome: its origin and clinical application. Br J Dermatol 1993;128:124-9.
34. Goldman BD, Se-Kyung Oh, Bret ED, et al. Serum soluble Interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photophoresis-based treatment. Arch Dermatol 1993;129:1166-70.
35. Neish C, Charley M, Tharp M, et al. Expression of class II antigens and IL-2 receptor (IL-2) on cells from skin infiltrates and periph- eral blood mononuclear cells (PBL) of CTCL patients [Abstract]. J Invest Dermatol 1989;92:490.
36. Neish C, Charley M, Jegasothy B, et al. Proliferation cell nuclear antigen and soluble interleukin 2 receptor levels in cutaneous T- cell lymphoma: correlation with advanced clinical diseases. J Dermatol Sci 1994;8:11-7.
37. Dummer R, Burg G. Soluble Interleukin-2 receptors and cutaneous T-cell lymphoma, Cancer 1993;71:3793-4.
38. Boehncke WH, Gerdes J, Wiese M. A majority of proliferating T-cell lymphomas may lack the high affinity of IL-2 receptor (CD25). Arch Dermatol Res 1993;285:127-30.